Point of Care Decision Support

Point of Care Decision Support Partners & Associations

Point of Care Decision Support's corporate commitment to keep up with the latest industry requirements, expand our capabilities and expertise, and deliver quality solutions to all of our clients, allows us to partner with some of the most successful companies in the industry. 

If you are interested in learning more about our capabilities or to join our growing team of partners, please contact us



The Anticoagulation Forum is the largest peer organization of anticoagulant service providers in North America. Membership includes more than 6,000 physicians, nurses, and pharmacists representing over 2,000 anticoagulation services (clinics). Members directly support over 750,000 patients annually.

As the premier provider of education and the authoritative voice among anticoagulation professionals, the AC Forum offers insight and expertise to those on the front lines. Visit www.acforum.org.

Allscripts® is a leader in EHR integration and healthcare information technology solutions that advance clinical, financial and operational results. Allscripts has certified Point of Care for its anticoagulation solution. Point of Care AC introduces a real-time application optimizing safety and therapy, and transform evidence-based guidelines into robust, intelligent tools for tracking and evaluating real-time patient therapy protocols and drug reaction history.

Featuring the industry’s most innovative Healthcare IT developers, the award winning Allscripts Developer Program connects caregivers instantly with apps to help increase productivity, deliver higher-quality, more personalized care, seamlessly integrate devices and much more. Allscripts clients can learn more about Point of Care AC here and on the Allscripts Application Store.

The company’s lead product is the Coag-Sense PT/INR Monitoring System, which incorporates a novel direct micromechanical clot-detection technology. This proprietary technology emulates the World Health Organization (WHO) gold standard tilt-tube method while requiring only a very small blood sample.

Direct clot-detection technology provides clinicians with the system reliability they demand and patients with the comfort of knowing that proper home testing can provide dependable results like a laboratory. In 2016, CoaguSense was acquired by i-SENS, Inc.—a leader in point-of-care diagnostic technology and manufacturing. Further information about CoaguSense can be found at www.coag-sense.com

IPRO is a national organization providing a full spectrum of healthcare assessment and improvement services that foster more efficient use of resources and enhance healthcare quality to achieve better patient outcomes.  For more information, visit www.IPRO.org.

Medical Alley is a global leader in enabling health technology and care organizations to innovate, succeed and influence the evolution of healthcare by influencing policy, delivering actionable information and intelligence, and connecting members with critical resources, working to ensure that Minnesota's Medical Alley remains the world's strongest health technology community.  For more information, visit www.medicalalley.org